Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting up to 20% of women of reproductive age worldwide. Characterized by symptoms such as irregular menstrual cycles, excess androgen levels, and polycystic ovaries, PCOS is a leading cause of infertility. Beyond these reproductive concerns, the syndrome is accompanied by systemic risks, including metabolic disturbances and increased susceptibility to gestational complications such as miscarriage, gestational diabetes, and preterm birth. While fertility treatments can assist women with PCOS in achieving pregnancy, they do not eliminate the heightened risks associated with pregnancy outcomes.
Scientific and Clinical Evidence: What the Data Tell Us
Recent research presented at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) has shed light on the microbiota and metabolic factors influencing these risks. In a study involving 220 women under the age of 35, researchers compared gut microbiota and serum metabolomic profiles between 110 PCOS patients and 110 matched controls. The findings were striking, revealing distinct differences in gut microbial diversity and metabolic markers linked to pregnancy outcomes.